Skip to main content
Premium Trial:

Request an Annual Quote

Another Company, Another Childhood

Premium

Frank Lee swears it’s not a midlife crisis. Lee, 49, left his CTO post at Millennium Pharmaceuticals to become president and CEO of EngeneOS, a startup with fewer than 10 employees incubated by NewcoGen. “I was interested in going back to an earlier stage company,” says Lee, who remembers well Millennium’s nascent phase. Another attraction was the added responsibility: “I wanted to move from the pure science and technology role.”

The switch to CEO and president should accomplish that. EngeneOS hopes to develop a business around disciplines as varied as biology, genomics, physics, engineering, and electronics. The goal is to engineer electronic devices using peptides or nucleic acids as scaffolds. Potential applications exist in pharmaceuticals, diagnostics, and chemical synthesis.

Lee expects the company to grow through internal expansion of its science and business teams as well as through strategic partnerships. Lee, whose background is in molecular biology, considers his move to EngeneOS an “opportunity to do something fun and different.”

— Meredith Salisbury

 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.